FindTrial
Sign In

Impact of sedation with dexmedetomidine during percutaneous coronary intervention on postoperative outcomes in myocardial infarction patients

Impact of sedation with dexmedetomidine during percutaneous coronary intervention on postoperative outcomes in myocardial infarction patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006453
Enrollment
Unknown
Registered
2015-05-27
Start date
2015-06-29
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative myocardial protection

Interventions

dexmedetomidine group :dexmedetomidine
control group:midazolam

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients between the ages of 18 and 75 years with ASA classification 17 of I or II undergoing percutaneous coronary intervention under sedation were eligible for inclusion in the study

Exclusion criteria

Exclusion criteria: Exclusion criteria were known allergy to a-2 agonists, respiratory problems (pneumonia, asthma, bronchitis and severe obstructive sleep apnea), sinus bradycardia (<50bpm), severe arrhythmia, uncooperative

Design outcomes

Primary

MeasureTime frame
hemodynamic changes;sedation scores;LVEF;cTnI;NGAL;—

Countries

China

Contacts

Public ContactFu-hai Ji
jifuhai@hotmail.com+86 13656207331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026